With 0.14 million shares changed hands, the volume of the stock remained heavier than its average volume of 55230.0 shares. During the session, the Medical Devices company that operates in wider Healthcare sector, reached to the highest price of $33.07 whereas the lowest price it dropped to was $28.69. The 52-week range on SNWV shows that it touched its highest point at $39.50 and its lowest point at $5.18 during that stretch. It currently has a 1-year price target of $0.75. Beta for the stock currently stands at 1.19.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of SNWV was up-trending over the past week, with a rise of 5.20%, but this was up by 11.56% over a month. Three-month performance surged to 4.07% while six-month performance rose 63.04%. The stock gained 437.24% in the past year, while it has gained 43.48% so far this year.
Float and Shares Shorts:
At present, 8.55 million SNWV shares are outstanding with a float of 7.83 million shares on hand for trading. On 2025-05-30, short shares totaled 48021.0, which was 55.99999999999999 higher than short shares on 1745971200. In addition to Mr. Morgan C. Frank as the firm’s CEO & Chairman, Mr. Andrew Walko serves as its President.
Institutional Ownership:
Through their ownership of 0.29352 of SNWV’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2025-03-31, SNWV reported revenue of $9342000.0 and operating income of $986000.0. The EBITDA in the recently reported quarter was $1351000.0 and diluted EPS was -$0.66.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.
